EP MedSystems, Inc. v. EchoCath, Inc.
United States Court of Appeals for the Third Circuit
235 F.3d 865 (2000)
EchoCath, Inc. (EchoCath) (defendant), a medical research and development company, developed ultrasound technology that allowed doctors to perform certain medical procedures more safely and efficiently. In 1996, EchoCath began an initial public offering and issued a prospectus containing cautionary language that the investment was speculative and involved high risk. EchoCath disclosed to potential investors that EchoCath planned to pursue joint ventures with other companies, but that there were no guarantees of success. EP MedSystems, Inc. (MedSystems) (plaintiff) considered making a large investment in EchoCath. Throughout the negotiations between MedSystems and EchoCath, EchoCath’s officers and directors represented that EchoCath was deep in negotiations with large corporations to develop and market its women’s products. MedSystems agreed to purchase $1,400,000 in EchoCath stock and signed a subscription agreement stating that MedSystems was relying solely on information provided in the sales materials from EchoCath. However, fifteen months after MedSystems invested, EchoCath had not entered into any contracts to market its women’s products. MedSystems brought action against EchoCath, alleging that EchoCath had made misleading oral misrepresentations in violation of federal securities laws and certain state laws to induce MedSystems to invest. EchoCath moved to dismiss the complaint, relying on the cautionary statements in the offering materials. The district court dismissed MedSystems’ complaint, finding that EchoCath’s representations were immaterial under the bespeaks-caution doctrine and that MedSystems had failed to establish scienter, reliance, or loss causation.
Rule of Law
Holding and Reasoning (Sloviter, J.)
What to do next…
Unlock this case brief with a free (no-commitment) trial membership of Quimbee.
You’ll be in good company: Quimbee is one of the most widely used and trusted sites for law students, serving more than 97,000 law students since 2011. Some law schools—such as Yale, Vanderbilt, Berkeley, and the University of Illinois—even subscribe directly to Quimbee for all their law students. Read our student testimonials.
Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school.
Quimbee is a company hell-bent on one thing: helping you get an “A” in every course you take in law school, so you can graduate at the top of your class and get a high-paying law job. We’re not just a study aid for law students; we’re the study aid for law students. Read more about Quimbee.
Here's why 175,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 14,000 briefs, keyed to 188 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.